Schering-Plough/Merck File Claritin, Singulair Combination
This article was originally published in The Pink Sheet Daily
Executive Summary
NDA has been accepted by FDA for a standard 10-month review.
You may also be interested in...
Schering-Plough’s Cholesterol Franchise Holds 16.4 Percent Of New Scripts
Sales of Vytorin and Zetia climb 48 percent to $1.2 billion during the first quarter.
J.P. Morgan, Without The Parties, Reveals An Industry Ready To Get Down To Business
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US COVID-19 Vaccination Rollout On Track After Early Bumps, J.P. Morgan Panelists Say
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: